A minimally invasive treatment that reduces urinary tract symptoms for men with enlarged prostates maintains its effectiveness for at least three years after patients undergo the therapy, according to new research. This study of 1,000 men is the largest of its kind to evaluate the long-term effectiveness of prostate artery embolization (PAE).